Solutions in Critical Care secures exclusive rights in the US to carry Inovytec’s Ventway Sparrow EMS and MRI ventilators.
Solutions in Critical Care announced they have entered into a long-term agreement to carry Inovytec’s Ventway Sparrow EMS and MRI Ventilators. The Ventway Sparrow is a groundbreaking family of transport and emergency ventilators designed to stand up to the harshest conditions while providing reliable, high-performance ventilation.
Latest Aithority Insights: AudioCodes Is an Approved Partner for Microsoft’s Operator Connect Accelerator
“Solutions in Critical Care strives to bring innovative technology to our customers in the US and we have done just that with the introduction of the Ventway Sparrow. At only 1kg, it brings a level of care unprecedented in a ventilator of this size. We are looking to expand the use of ventilation for First Responders and other frontline caregivers to provide a safe and effective tool in transporting critical patients,” said Bill Carmouche, V.P. Business Development at Solutions in Critical Care.
Design and Performance
The Ventway Sparrow provides an unparalleled continuum of ventilation, supporting all the major ventilation modes for adults and pediatric patients (invasive and non-invasive).
Browse The Complete News About Aithority: Fuel Cycle Selects Canvs AI as Premier Text Analytics Solution on Fuel Cycle Exchange
Advanced Features
- Compact & Light Weight – Weighing only 1kg makes it optimal for patient transport, both in and out of the hospital.
- Oxygen-Independent Operation – By Utilizing a turbine to draw ambient air from its surroundings, the Ventway does not rely solely on an external oxygen supply.
- From the Point of Injury to The Hospital – The Ventway provides an unparalleled continuum of ventilation in one compact package.
- Affordable and Easily Maintained – The Ventway is cost-effective and low maintenance.
Read More About Aithority News : Mindtree and Sapiens Announce Partnership to Digitally Transform the Insurance Industry
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.